Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.9 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.17 | 0.9 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |